NEPH · NASDAQ
Nephros, Inc.
$3.08 -0.12 (-3.75%)
Company overview
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NASDAQ
- Market cap
- $33.5M
- Employees
- 31
- Headquarters
- South Orange, NJ
- Website
- nephros.com
- CEO
- Robert Banks
- Listed
- September 21, 2004
- P/E
- 42.13
- Dividend yield
- 0.00%
Company financials
- Revenue
- $19.1M
- Gross profit
- $11.3M
- Operating income
- $677,000
- EBITDA
- $814,000
- Net income
- $776,000
- EPS
- $0.07
- Total assets
- $13.8M
- Total debt
- $968,000
- Gross margin
- 59.06%
- Net margin
- 4.06%
- Earnings yield
- 2.37%
No geographic segmentation.
Showing FY 2025
NEPH
1D
NASDAQ
O3.28H3.30L3.20C3.25+0.01 (+0.31%)Vol10.37K
News